The U.S. Food and Drug Administration hosts a public workshop at 9 a.m. ET on July 15 to discuss the development of antihypertensive therapies for pediatric patients. The workshop brings together clinicians, researchers, regulators, industry representatives, and patient advocates to explore treatment strategies, drug development priorities, and evidence for the safe and effective use of blood pressure medications in children, including those under age 6.
…Â
LIVE NOW: FDA Workshop Focuses on Pediatric Hypertension Treatments (DAY 1)
